Pediatric Asthma - Persistent Colds or Something More?
Department of Pediatric Allergy, Immunology, and Rheumatology Dr. Pin-Chia Huang
Specialties: General Pediatrics,
Vaccinations, Health Screenings, Atopic Dermatitis, Allergic Rhinitis, Night
Cough, Asthma, Urticaria, Arthritis, Pediatric Autoimmune Diseases, Primary
Immunodeficiency.
Definition and Clinical Features
of Asthma
Asthma is a highly heterogeneous disease characterized
primarily by chronic airway inflammation. Diagnosis is based on a
history of respiratory symptoms, including:
- Wheeze
- Shortness
of breath, chest tightness, and cough.
- Variable
severity:
Airflow obstruction varies based on triggers such as exercise, allergens,
weather changes, or viral infections.
- Persistent
Inflammation:
Chronic inflammation can exist even when a patient has been symptom-free
for weeks or months, which is why long-term maintenance therapy is
crucial.

Diagnostic Workflow for Children
Under 5
According to the GINA 2025 (Global Strategy
for Asthma Management and Prevention) framework, a definitive diagnosis
requires meeting these three criteria:
- Recurrent
acute wheezing episode(s): Two or more acute wheezing episodes in the past 12 months, or one
episode plus asthma-like symptoms between events (e.g., symptoms worse
during sleep, or after laughing, crying or activity).
- No
likely alternative cause for the respiratory symptoms
- A timely
clinical response to asthma treatment: Significant clinical improvement after using
asthma medications, specifically SABA (short-acting beta2
agonists) or a trial of inhaled corticosteroids for 2–3 months.
Note:
If these criteria are not met, the condition is classified as
"suspected" asthma requiring further observation. Personal history of
allergies (e.g., allergic rhinitis) or a family history of asthma are used as
supplementary diagnostic factors.

The Role of FeNO (Fractional
Exhaled Nitric Oxide)
FeNO is a biomarker used to assess Type 2 airway
inflammation.
- Diagnostic
Support: A
FeNO level > 35 ppb in children (or > 50 ppb in
adults/adolescents) supports a Type 2 asthma diagnosis when typical
symptoms are present.
- Limitations: FeNO alone cannot diagnose
asthma. It may be elevated in non-asthma conditions like atopic dermatitis
or allergic rhinitis, and it may remain normal in specific asthma
phenotypes (e.g., obesity-related asthma).
- Variables: Levels can be influenced by
age, gender, time of day, and smoking status. Testing should be performed
when the patient is stable and free from viral infections.

Conclusion
For patients with confirmed or suspected asthma, high
FeNO levels can support the decision to start inhaled corticosteroid therapy.
Our Pediatric Pulmonary Function Lab offers FeNO testing, which is non-invasive
and easy for young children to perform. It serves as a valuable tool for
diagnosis, assessing treatment response, and determining prognosis.